Tandem Diabetes Care, Inc. Financing Cash Flow
Tandem Diabetes Care, Inc. (TNDM) reported Financing Cash Flow of $276.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Tandem Diabetes Care, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $2.15M.
- Tandem Diabetes Care, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $274.16M.
- Tandem Diabetes Care, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.60M, a 13.12% increase year-over-year.
- Tandem Diabetes Care, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$1.57M.
- Tandem Diabetes Care, Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$43.37M, a 618.31% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $8.37M, a 103.43% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $4.11M, a 75.63% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $16.88M, a 67.50% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $276.31M 10-Q · filed 2026-08-06 | $278.92M derived: sum of 3 quarters · filed 2026-08-06 | $277.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $274.16M 10-Q · filed 2026-05-07 | $276.76M derived: sum of 2 quarters · filed 2026-05-07 | $275.19M derived: sum of 3 quarters · filed 2026-05-07 | $235.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.03M derived: sum of 2 quarters · filed 2026-02-19 | -$38.68M derived: sum of 3 quarters · filed 2026-08-06 | -$43.37M 10-K · filed 2026-02-19 |
| 2025-09-30 | -$1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$41.28M derived: sum of 2 quarters · filed 2026-08-06 | -$45.97M 10-Q · filed 2025-11-06 | -$43.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$39.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$44.40M 10-Q · filed 2026-08-06 | -$42.10M derived: sum of 3 quarters · filed 2026-08-06 | -$46.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$4.69M 10-Q · filed 2026-05-07 | -$2.39M derived: sum of 2 quarters · filed 2026-05-07 | -$6.91M derived: sum of 3 quarters · filed 2026-05-07 | -$9.91M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$2.22M derived: sum of 2 quarters · filed 2026-02-19 | -$5.22M derived: sum of 3 quarters · filed 2026-02-19 | $8.37M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$7.52M derived: sum of 2 quarters · filed 2025-11-06 | $6.07M 10-Q · filed 2025-11-06 | $8.68M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $10.58M 10-Q · filed 2025-08-06 | $13.20M derived: sum of 3 quarters · filed 2026-02-19 | $11.29M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $13.59M 10-Q · filed 2025-04-30 | $16.20M derived: sum of 2 quarters · filed 2026-02-19 | $14.29M derived: sum of 3 quarters · filed 2026-02-19 | $18.24M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $706.00K derived: sum of 2 quarters · filed 2026-02-19 | $4.65M derived: sum of 3 quarters · filed 2026-02-19 | $4.11M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$1.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.04M derived: sum of 2 quarters · filed 2024-11-06 | $1.50M 10-Q · filed 2024-11-06 | $7.60M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $3.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $3.41M 10-Q · filed 2024-08-01 | $9.51M derived: sum of 3 quarters · filed 2025-02-26 | $8.73M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$541.00K 10-Q · filed 2024-05-02 | $5.56M derived: sum of 2 quarters · filed 2025-02-26 | $4.79M derived: sum of 3 quarters · filed 2025-02-26 | $12.84M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $5.33M derived: sum of 2 quarters · filed 2025-02-26 | $13.38M derived: sum of 3 quarters · filed 2025-02-26 | $16.88M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$774.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $7.28M derived: sum of 2 quarters · filed 2023-11-01 | $10.78M 10-Q · filed 2023-11-01 | $26.66M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $8.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $11.55M 10-Q · filed 2023-08-03 | $27.44M derived: sum of 3 quarters · filed 2024-02-21 | $46.29M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $3.50M 10-Q · filed 2023-05-03 | $19.39M derived: sum of 2 quarters · filed 2024-02-21 | $38.24M derived: sum of 3 quarters · filed 2024-02-21 | $51.86M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $15.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $34.74M derived: sum of 2 quarters · filed 2024-02-21 | $48.36M derived: sum of 3 quarters · filed 2024-02-21 | $51.93M 10-K · filed 2024-02-21 |
| 2021-09-30 | $18.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $32.47M derived: sum of 2 quarters · filed 2022-11-02 | $36.05M 10-Q · filed 2022-11-02 | $45.25M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $13.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $17.20M 10-Q · filed 2022-08-03 | $26.40M derived: sum of 3 quarters · filed 2023-02-22 | $56.33M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $3.57M 10-Q · filed 2022-05-04 | $12.78M derived: sum of 2 quarters · filed 2023-02-22 | $42.71M derived: sum of 3 quarters · filed 2023-02-22 | $306.53M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $39.13M derived: sum of 2 quarters · filed 2023-02-22 | $302.96M derived: sum of 3 quarters · filed 2023-02-22 | $314.44M 10-K · filed 2023-02-22 |
| 2020-09-30 | $29.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $293.75M derived: sum of 2 quarters · filed 2021-11-03 | $305.23M 10-Q · filed 2021-11-03 | $311.65M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $263.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $275.30M 10-Q · filed 2021-08-04 | $281.72M derived: sum of 3 quarters · filed 2022-02-22 | $288.75M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $11.48M 10-Q · filed 2021-05-05 | $17.90M derived: sum of 2 quarters · filed 2022-02-22 | $24.93M derived: sum of 3 quarters · filed 2022-02-22 | $33.73M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $13.45M derived: sum of 2 quarters · filed 2022-02-22 | $22.25M derived: sum of 3 quarters · filed 2022-02-22 | $24.21M 10-K · filed 2022-02-22 |
| 2019-09-30 | $7.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $15.83M derived: sum of 2 quarters · filed 2020-11-05 | $17.79M 10-Q · filed 2020-11-05 | $19.75M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $8.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $10.76M 10-Q · filed 2020-07-30 | $12.71M derived: sum of 3 quarters · filed 2021-02-24 | $34.76M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $1.96M 10-Q · filed 2020-04-30 | $3.92M derived: sum of 2 quarters · filed 2021-02-24 | $25.97M derived: sum of 3 quarters · filed 2021-02-24 | $48.48M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $24.00M derived: sum of 2 quarters · filed 2021-02-24 | $46.52M derived: sum of 3 quarters · filed 2021-02-24 | $117.18M 10-K · filed 2021-02-24 |
| 2018-09-30 | $22.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $44.56M derived: sum of 2 quarters · filed 2019-11-04 | $115.23M 10-Q · filed 2019-11-04 | $129.91M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $22.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $93.18M 10-Q · filed 2019-08-01 | $107.86M derived: sum of 3 quarters · filed 2020-02-24 | $111.85M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $70.67M 10-Q · filed 2019-04-30 | $85.35M derived: sum of 2 quarters · filed 2020-02-24 | $89.34M derived: sum of 3 quarters · filed 2020-02-24 | |
| 2017-12-31 | $14.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $18.67M derived: sum of 2 quarters · filed 2020-02-24 | $40.38M 10-K · filed 2020-02-24 | |
| 2017-09-30 | $3.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $25.70M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | $21.70M 10-Q · filed 2018-07-30 | |||
| 2016-12-31 | $52.31M 10-K · filed 2019-02-26 | |||
| 2014-03-31 | $26.75K 10-Q · filed 2014-05-06 | |||
| 2013-03-31 | $22.49M 10-Q · filed 2014-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |